| scholarly article | Q13442814 |
| P2093 | author name string | X Wu | |
| F Wang | |||
| W L McKeehan | |||
| M Kan | |||
| P2860 | cites work | A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor | Q41091047 |
| Identification of glypican as a dual modulator of the biological activity of fibroblast growth factors | Q41110684 | ||
| Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells | Q41134771 | ||
| Identification and assay of fibroblast growth factor receptors | Q41706529 | ||
| Heparan sulfate is required for interaction and activation of the epithelial cell fibroblast growth factor receptor-2IIIb with stromal-derived fibroblast growth factor-7. | Q42061209 | ||
| Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1. | Q42807941 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| High salt inhibits both heparin-dependent and heparin-independent complexes of fibroblast growth factor and the receptor kinase. | Q52561654 | ||
| Receptor specificity of the fibroblast growth factor family | Q24320178 | ||
| Structure of a heparin-linked biologically active dimer of fibroblast growth factor | Q27760195 | ||
| Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 | Q28273441 | ||
| Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration | Q34307150 | ||
| Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor | Q38334436 | ||
| Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate | Q38338357 | ||
| Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 | ||
| Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor. | Q38346690 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15947-52 | |
| P577 | publication date | 1999-05-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase | |
| P478 | volume | 274 |
| Q24685118 | A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice |
| Q40832433 | A novel alternatively spliced fibroblast growth factor receptor 3 isoform lacking the acid box domain is expressed during chondrogenic differentiation of ATDC5 cells |
| Q35103291 | Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease |
| Q38922385 | Activation of FGF receptor signaling promotes invasion of non-small-cell lung cancer |
| Q88936926 | Basement Membranes in Development and Disease |
| Q38302571 | Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4. |
| Q44591813 | Biospecific Extraction and Neutralization of Anticoagulant Heparin with Fibroblast Growth Factors (FGF) |
| Q38977291 | Cardiac actions of fibroblast growth factor 23. |
| Q40730239 | Cell- and receptor isotype-specific phosphorylation of SNT1 by fibroblast growth factor receptor tyrosine kinases |
| Q33767961 | Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo |
| Q31036531 | Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection |
| Q35010389 | Co-administration of cyclosporine an alleviates thioacetamide-induced liver injury |
| Q42801360 | Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs |
| Q34258918 | Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations |
| Q58418712 | Depot-Specific Expression of Fibroblast Growth Factors in Human Adipose Tissue |
| Q39374896 | Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB. |
| Q37256534 | Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation. |
| Q77178108 | Directional specificity of prostate stromal to epithelial cell communication via FGF7/FGFR2 is set by cell- and FGFR2 isoform-specific heparan sulfate |
| Q28590891 | Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4 |
| Q36332838 | Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. |
| Q35043172 | Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy |
| Q30443021 | Evidence for digenic inheritance in some cases of Antley-Bixler syndrome? |
| Q74456882 | Expression and biological effect of urodele fibroblast growth factor 1: relationship to limb regeneration |
| Q52052484 | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. |
| Q40593865 | Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines |
| Q37376265 | FGFR4 and TGF-β1 expression in hepatocellular carcinoma: correlation with clinicopathological features and prognosis |
| Q58377532 | Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate |
| Q45143894 | Fibroblast growth factor (Fgf) signaling pathway regulates liver homeostasis in zebrafish |
| Q42704110 | Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease |
| Q38923517 | Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma |
| Q35364559 | Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma |
| Q35231830 | Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. |
| Q44508747 | Fibroblast growth factor receptor signalling is crucial for liver homeostasis and regeneration |
| Q33179207 | Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides |
| Q24534355 | Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts |
| Q43597363 | Fibroblast growth factors 1 and 2 differently activate MAP kinase in Xenopus oocytes expressing fibroblast growth factor receptors 1 and 4. |
| Q36923642 | Fibroblast growth factors, old kids on the new block |
| Q38784876 | Function of Membrane-Associated Proteoglycans in the Regulation of Satellite Cell Growth |
| Q43096150 | HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses. |
| Q41504553 | Heparanase Inhibitors Facilitate the Assembly of the Basement Membrane in Artificial Skin |
| Q34222480 | Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action. |
| Q36625238 | Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer |
| Q22253352 | Identification of endoglycan, a member of the CD34/podocalyxin family of sialomucins |
| Q24684986 | Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice |
| Q45305228 | Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids |
| Q54195848 | Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma. |
| Q40337083 | Inhibition or activation of Apert syndrome FGFR2 (S252W) signaling by specific glycosaminoglycans |
| Q28740388 | Interferon-α/β and anti-fibroblast growth factor receptor 1 monoclonal antibody suppress hepatic cancer cells in vitro and in vivo |
| Q33751398 | Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? |
| Q35991812 | Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma |
| Q35764259 | Mechanistic diversity of cytokine receptor signaling across cell membranes |
| Q39676210 | Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation |
| Q34114308 | Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors |
| Q26738860 | Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker Selection |
| Q43568416 | Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling |
| Q38990794 | Regulation of metastasis of pediatric multiple myeloma by MMP13. |
| Q41839560 | Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis |
| Q35792203 | Role of Fibroblast Growth Factor Type 1 and 2 in Carbon Tetrachloride-Induced Hepatic Injury and Fibrogenesis |
| Q33369576 | Role of fibroblast growth factor-binding protein in the pathogenesis of HIV-associated hemolytic uremic syndrome |
| Q28646255 | Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells |
| Q37512367 | Signals and cells involved in regulating liver regeneration |
| Q36324847 | Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly |
| Q27673616 | Structural basis of heparan sulfate-specific degradation by heparinase III |
| Q40630770 | Sulfated Derivatives of Escherichia coli K5 Polysaccharides as Modulators of Fibroblast Growth Factor Signaling |
| Q24306135 | Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho |
| Q35219630 | Syndecan-4: dispensable or indispensable? |
| Q38176101 | Targeted inhibition of the FGF19-FGFR4 pathway in hepatocellular carcinoma; translational safety considerations |
| Q42343453 | Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. |
| Q28729944 | Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models |
| Q38303270 | Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target. |
| Q54649699 | The Fibroblast Growth Factor Receptor-4 Arg388 Allele is Associated with Gastric Cancer Progression |
| Q92959917 | The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia |
| Q30432483 | The extracellular matrix in development and morphogenesis: a dynamic view |
| Q35006524 | Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway |
| Q44235710 | Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling |
| Q34576805 | βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway |
Search more.